Abstract:Streptococcus suis, a major zoonotic pathogen in swine, can be classified into 35 serotypes. However, no universal vaccine against the multiple serotypes of S. suis is available, though some studies have shown homologous protection. Hence, developing an effective universal vaccine to protect pigs against multiple S. suis serotypes is necessary, or at the very least, to protect pigs against diseases caused by the dominant pathogenic serotypes. Enolase, a highly conserved surface protein, is present in all of the described S. suis serotypes. rSC0016 is an improved recombinant attenuated S. Choleraesuis vaccine vector, combining a sopB mutation with regulated delayed systems, achieving an adequate balance between host safety and immunogenicity. In order to develop a universal vaccine against the multiple serotypes of S. suis, a novel recombinant vaccine strain rSC0016 that carries a heterologous antigen enolase was developed in this study. According, it was found that the recombinant vaccine strain rSC0016(pS-Enolase) exhibited better colonization compared to the vaccine control strain rSC0018(pYA3493). In addition, a mouse model immunized with the strain rSC0016(pS-Enolase) elicited significant IgG antibody responses against both enolase and Salmonella antigens, while inducing good mucosal, humoral, and cellular immune responses against enolase. Finally, immunization with rSC0016(pS-Enolase) was shown to confer 100%, 80%, and 100% protection against the serotypes of SS2, SS7, and SS9, respectively, and significantly reduced histopathological lesions in mice. Overall, this study provides a promising universal vaccine candidate for use against the multiple serotypes of S. suis.

Characterization of chicken-derived antibody against Alpha-Enolase of Streptococcus pneumoniae

Generation and Characterization of Single Chain Variable Fragment against Alpha-Enolase of Candida albicans

Alpha-Enolase, An Adhesion-Related Factor Of Mycoplasma Bovis

Lactococcus Lactisanchoring Avian Infectious Bronchitis Virus Multi-Epitope Peptide EpiC Induced Specific Immune Responses in Chickens

Development of a Blocking ELISA for Detection of Mycoplasma Hyopneumoniae Infection Based on a Monoclonal Antibody Against Protein P65.

Generation and Characterization of Specific Chicken Egg Yolk Immunoglobulins Against Nucleocapsid Protein of Porcine Reproductive and Respiratory Syndrome Virus

High-Level Expression, Purification, Polyclonal Antibody Preparation Against Recombinant Oprd from Pseudomonas Aeruginosa

Molecular and biochemical characterization of enolase from Dermanyssus gallinae

Novel Immunoprotective Proteins of Streptococcus Pneumoniae Identified by Opsonophagocytosis Killing Screen

Evaluation of the protective efficacy of six major immunogenic proteins of Mycoplasma Synoviae

Mycoplasma suis Alpha-Enolase Subunit Vaccine Induces an Immune Response in Experimental Animals

Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a conserved surface protein enolase induces high and broad protection against Streptococcus suis serotypes 2, 7, and 9 in mice

Streptococcus suis enolase functions as a protective antigen displayed on the bacterial cell surface.

Selection and Characterization, Application of a DNA Aptamer Targeted to Streptococcus Pyogenes in Cooked Chicken.

Generation and Characterization of Monoclonal Antibodies Against Enrofloxacin

Expression and Immunological Characterization of the Major Epitope of P1 Adhesin Protein of Mycoplasma Pneumoniae and Its Clinical Application Research

Selection and characterization of single-chain recombinant antibodies against phosphoprotein of Newcastle disease virus.

Construction and Validation of Chicken Immune scFv Antibody Library against Helicobacter pylori

Elevated Mhp462 antibody induced by natural infection but not in vitro culture of Mycoplasma hyopneumoniae

Surface display of Clonorchis sinensis enolase on Bacillus subtilis spores potentializes an oral vaccine candidate

De novo identification of bacterial antigens of a clinical isolate by combining use of proteosurfaceomics, secretomics, and BacScan technologies